Kiora Pharmaceuticals Reports Q3 2026 Results, Advances KIO-401 Development
Kiora Pharmaceuticals reported third-quarter 2026 collaboration revenue of $1.0 million and a net loss of $1.75 million, compared with no revenue and net income of $26,806 in the year-earlier quarter. The company ended September with $16.3 million in cash and short-term investments. Its business up…